Falkenberg FW - Search Results

1

Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.

Galloway DR, Li J, Nguyen NX, Falkenberg FW, Henning L, Krile R, Chou YL, Herron JN, Hale JS, Williamson ED. Galloway DR, et al. Among authors: falkenberg fw. Front Immunol. 2024 Mar 28;15:1277526. doi: 10.3389/fimmu.2024.1277526. eCollection 2024. Front Immunol. 2024. PMID: 38605961 Free PMC article.

2

The magnitude of the germinal center B cell and T follicular helper cell response predicts long-lasting antibody titers to plague vaccination.

Galloway DR, Nguyen NX, Li J, Houston N, Gregersen G, Williamson ED, Falkenberg FW, Herron JN, Hale JS. Galloway DR, et al. Among authors: falkenberg fw. Front Immunol. 2022 Oct 28;13:1017385. doi: 10.3389/fimmu.2022.1017385. eCollection 2022. Front Immunol. 2022. PMID: 36389793 Free PMC article.

3

Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trial.

Koc ÖM, de Smedt P, Kremer C, Robaeys G, van Damme P, Hens N, Almeida J, Falkenberg F, Savelkoul P, Oude Lashof A; BE RESPONDER Study Group. Koc ÖM, et al. Liver Int. 2021 Oct;41(10):2318-2327. doi: 10.1111/liv.14939. Epub 2021 May 24. Liver Int. 2021. PMID: 33966331 Free PMC article. Clinical Trial.

4

The 180 splice variant of NCAM-containing exon 18-is specifically expressed in small cell lung cancer cells.

Vander Borght A, Duysinx M, Broers JLV, Ummelen M, Falkenberg FW, Hahnel C, van der Zeijst BAM. Vander Borght A, et al. Among authors: falkenberg fw. Transl Lung Cancer Res. 2018 Jun;7(3):376-388. doi: 10.21037/tlcr.2018.03.03. Transl Lung Cancer Res. 2018. PMID: 30050775 Free PMC article.

5

Characterization of renal papillary antigen 1 (RPA-1), a biomarker of renal papillary necrosis.

Price SA, Davies D, Rowlinson R, Copley CG, Roche A, Falkenberg FW, Riccardi D, Betton GR. Price SA, et al. Among authors: falkenberg fw. Toxicol Pathol. 2010 Apr;38(3):346-58. doi: 10.1177/0192623310362246. Epub 2010 Mar 16. Toxicol Pathol. 2010. PMID: 20233945

6

A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells.

Grille S, Brugnini A, Nese M, Corley E, Falkenberg FW, Lens D, Chabalgoity JA. Grille S, et al. Among authors: falkenberg fw. Cancer Immunol Immunother. 2010 Apr;59(4):519-27. doi: 10.1007/s00262-009-0768-6. Epub 2009 Sep 19. Cancer Immunol Immunother. 2010. PMID: 19768458 Free PMC article.

7

The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.

Labarthe MC, Halanek N, Birchall L, Russell N, Desel C, Todryk S, Peters MJ, Lucas A, Falkenberg FW, Dalgleish AG, Whelan M, Ward SJ. Labarthe MC, et al. Among authors: falkenberg fw. Cancer Immunol Immunother. 2006 Mar;55(3):277-88. doi: 10.1007/s00262-005-0061-2. Epub 2005 Sep 13. Cancer Immunol Immunother. 2006. PMID: 16158275 Free PMC article.

8

B-cell epitopes of the allergen Chi t 1.01: peptide mapping of epitopes recognized by rabbit, murine, and human antibodies.

van Kampen V, Liebers V, Sander I, Chen Z, Baur X, Raulf-Heimsoth M, Falkenberg FW. van Kampen V, et al. Among authors: falkenberg fw. Allergy. 2001 Feb;56(2):118-25. doi: 10.1034/j.1398-9995.2001.056002118.x. Allergy. 2001. PMID: 11167371

9

Cytokine depot formulations as adjuvants for tumor vaccines. I. Liposome-encapsulated IL-2 as a depot formulation.

Krup OC, Kroll I, Böse G, Falkenberg FW. Krup OC, et al. Among authors: falkenberg fw. J Immunother. 1999 Nov;22(6):525-38. doi: 10.1097/00002371-199911000-00007. J Immunother. 1999. PMID: 10570751

10

Urinary antigens as markers of papillary toxicity. II: Application of monoclonal antibodies for the determination of papillary antigens in rat urine.

Hildebrand H, Rinke M, Schlüter G, Bomhard E, Falkenberg FW. Hildebrand H, et al. Among authors: falkenberg fw. Arch Toxicol. 1999 Jun-Jul;73(4-5):233-45. doi: 10.1007/s002040050612. Arch Toxicol. 1999. PMID: 10463389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters